Austro Labs Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 17-06-2024
- Paid Up Capital ₹ 6.00 M
as on 17-06-2024
- Company Age 11 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 Cr
as on 17-06-2024
- Satisfied Charges ₹ 9.95 Cr
as on 17-06-2024
- Revenue -4.22%
(FY 2023)
- Profit -47.48%
(FY 2023)
- Ebitda -32.20%
(FY 2023)
- Net Worth 12.12%
(FY 2023)
- Total Assets 19.78%
(FY 2023)
About Austro Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹9.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Goel, Mohit Goel, Vaibhav, and One other member serve as directors at the Company.
- CIN/LLPIN
U51101DL2013PLC261210
- Company No.
261210
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Austro Labs Limited offer?
Austro Labs Limited offers a wide range of products and services, including Common Disease Medicines, Ointment, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Cardiovascular Drugs & Medication, Kidney Drugs, Herbal Juice, Aloe Vera Juice, Nutraceuticals, Allopathic Immunity Booster.
Who are the key members and board of directors at Austro Labs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav  | Director | 28-Nov-2013 | Current |
| Naresh Goel | Director | 31-Jan-2014 | Current |
| Mohit Goel | Director | 28-Nov-2013 | Current |
| Ashok Agarwal | Director | 28-Nov-2013 | Current |
Financial Performance and Corporate Structure Insights of Austro Labs.
Austro Labs Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.22% decrease. The company also saw a substantial fall in profitability, with a 47.48% decrease in profit. The company's net worth Soared by an impressive increase of 12.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Austro Labs?
In 2023, Austro Labs had a promoter holding of 68.50% and a public holding of 31.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Warner India Lifesciences LimitedActive 13 years 3 months
Naresh Goel and Mohit Goel are mutual person
- Sentosa Geigy (India) Labs LimitedActive 14 years 10 months
Naresh Goel and Mohit Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 29 Aug 2022 | ₹10.00 Cr | Open |
Axis Bank Limited Creation Date: 18 Jul 2014 | ₹9.95 Cr | Satisfied |
How Many Employees Work at Austro Labs?
Austro Labs has a workforce of 10 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Austro Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Austro Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
